Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.

Shapiro AD, Angchaisuksiri P, Astermark J, Benson G, Castaman G, Chowdary P, Eichler H, Jiménez-Yuste V, Kavakli K, Matsushita T, Poulsen LH, Wheeler AP, Young G, Zupancic-Salek S, Oldenburg J.

Blood. 2019 Nov 28;134(22):1973-1982. doi: 10.1182/blood.2019001542.

PMID:
31444162
2.

Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years.

Osooli M, Donfield SM, Carlsson KS, Baghaei F, Holmström M, Berntorp E, Astermark J.

Haemophilia. 2019 Sep;25(5):845-850. doi: 10.1111/hae.13831. Epub 2019 Aug 14.

PMID:
31411798
3.

Hypertension and cardiovascular diseases in Swedish persons with haemophilia - A longitudinal registry study.

Lövdahl S, Henriksson KM, Baghaei F, Holmström M, Berntorp E, Astermark J.

Thromb Res. 2019 Sep;181:106-111. doi: 10.1016/j.thromres.2019.07.017. Epub 2019 Jul 21.

PMID:
31386935
4.

Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening.

Manderstedt E, Nilsson R, Lind-Halldén C, Ljung R, Astermark J, Halldén C.

PLoS One. 2019 Apr 26;14(4):e0216179. doi: 10.1371/journal.pone.0216179. eCollection 2019.

5.

Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis.

Versloot O, Berntorp E, Petrini P, Ljung R, Astermark J, Holmström M, de Kleijn P, Fischer K.

Haemophilia. 2019 Mar;25(2):244-251. doi: 10.1111/hae.13683. Epub 2019 Jan 28.

6.

The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia.

Strandberg K, Astermark J.

Haemophilia. 2018 May;24 Suppl 6:9-14. doi: 10.1111/hae.13474. Review.

PMID:
29878658
7.

European principles of inhibitor management in patients with haemophilia.

Giangrande PLF, Hermans C, O'Mahony B, de Kleijn P, Bedford M, Batorova A, Blatný J, Jansone K; European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD).

Orphanet J Rare Dis. 2018 Apr 27;13(1):66. doi: 10.1186/s13023-018-0800-z. Review.

8.

Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.

Osooli M, Steen Carlsson K, Astermark J, Berntorp E.

Haemophilia. 2017 Sep;23(5):e403-e408. doi: 10.1111/hae.13302. Epub 2017 Jul 31.

PMID:
28758324
9.

Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.

Kihlberg K, Strandberg K, Rosén S, Ljung R, Astermark J.

Haemophilia. 2017 Jul;23(4):620-627. doi: 10.1111/hae.13219. Epub 2017 Apr 24.

PMID:
28440032
10.

Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control study.

van Velzen AS, Eckhardt CL, Peters M, Leebeek FWG, Escuriola-Ettingshausen C, Hermans C, Keenan R, Astermark J, Male C, Peerlinck K, le Cessie S, van der Bom JG, Fijnvandraat K.

J Thromb Haemost. 2017 Jul;15(7):1422-1429. doi: 10.1111/jth.13711. Epub 2017 Jun 2.

11.

The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register.

Osooli M, Steen Carlsson K, Baghaei F, Holmström M, Rauchensteiner S, Holme PA, Hvitfeldt L, Astermark J, Berntorp E.

Haemophilia. 2017 May;23(3):e180-e187. doi: 10.1111/hae.13231. Epub 2017 Apr 10.

PMID:
28393468
12.

Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden.

Osooli M, Lövdahl S, Steen Carlsson K, Knobe K, Baghaei F, Holmström M, Astermark J, Berntorp E.

Haemophilia. 2017 Mar;23(2):e79-e86. doi: 10.1111/hae.13166. Epub 2017 Feb 2.

PMID:
28155262
13.

The importance of genetic factors for the development of arthropathy: a longitudinal study of children and adolescents with haemophilia A.

Gomperts ED, Schwarz J, Donfield SM, Lail AE, Astermark J, Hoots WK, Winkler CA, Berntorp E.

Thromb Haemost. 2017 Jan 26;117(2):277-285. doi: 10.1160/TH16-06-0440. Epub 2016 Dec 8.

PMID:
27929201
14.

Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics.

Kahle J, Orlowski A, Stichel D, Healey JF, Parker ET, Donfield SM, Astermark J, Berntorp E, Lollar P, Schwabe D, Königs C.

Haemophilia. 2017 Mar;23(2):292-299. doi: 10.1111/hae.13105. Epub 2016 Nov 8.

PMID:
27862687
15.

Outcome measures in European patients with haemophilia: Survey of implementation in routine clinical practice, perception of relevance and recommendations by European treaters in the EHTSB.

Hermans C, Klamroth R, Richards M, de Moerloose P, Garrido RP; EHTSB.

Haemophilia. 2017 Mar;23(2):222-229. doi: 10.1111/hae.13085. Epub 2016 Oct 27.

PMID:
27790841
16.

Current view and outcome of ITI therapy - A change over time?

Holstein K, Batorova A, Carvalho M, Fijnvandraat K, Holme P, Kavakli K, Lambert T, Rocino A, Jiménez-Yuste V, Astermark J; European Haemophilia Therapy Strategy Board (EHTSB).

Thromb Res. 2016 Dec;148:38-44. doi: 10.1016/j.thromres.2016.10.015. Epub 2016 Oct 15.

PMID:
27770665
17.

Partnering to change the world for people with haemophilia: 6(th) Haemophilia Global Summit, Prague, Czech Republic, 24-26(th) September 2015.

Astermark J, Hart D, Lobet S, Blatný J, d'Oiron R, Kenet G, Dolan G, Libotte V, Hermans C.

Eur J Haematol. 2016 Jul;97 Suppl 84:3-23. doi: 10.1111/ejh.12761.

PMID:
27292051
18.

Malignancies in Swedish persons with haemophilia: a longitudinal registry study.

Lövdahl S, Henriksson KM, Baghaei F, Holmström M, Berntorp E, Astermark J.

Blood Coagul Fibrinolysis. 2016 Sep;27(6):631-6. doi: 10.1097/MBC.0000000000000339.

PMID:
26974329
19.

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors.

van Velzen AS, Eckhardt CL, Streefkerk N, Peters M, Hart DP, Hamulyak K, Klamroth R, Meijer K, Nijziel M, Schinco P, Yee TT, van der Bom JG, Fijnvandraat K; INSIGHT study group.

Thromb Haemost. 2016 Mar;115(3):543-50. doi: 10.1160/TH15-03-0212. Epub 2015 Nov 19.

PMID:
26582077
20.

Inhibitor development in non-severe haemophilia across Europe.

Fischer K, Iorio A, Lassila R, Peyvandi F, Calizzani G, Gatt A, Lambert T, Windyga J, Gilman EA, Hollingsworth R, Makris M; EUHASS Participants.

Thromb Haemost. 2015 Oct;114(4):670-5. doi: 10.1160/TH14-12-1044. Epub 2015 Aug 13. Erratum in: Thromb Haemost. 2016 Mar;115(3):684. Hollingsworth, R [Added].

Supplemental Content

Loading ...
Support Center